Drugs / amoxicillin clavulanate potassium compound
amoxicillin clavulanate potassium compound
also known as
amoxicillin clavulanate potassium compound (Junerqing)
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01761214 Comparator | Sep 2012 → Dec 2023 | bronchiectasis | Guangzhou Institute of Respiratory Disease | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | amoxicillin clavulanate potassium compound | “In the present study, amoxicillin and amoxicillin clavulanate potassium compound are employed, based on the British Thoracic Society guideline for bronchietasis, as mainly...” NCT01761214 ↗ |
| Known as | amoxicillin clavulanate potassium compound (Junerqing) | “amoxicillin clavulanate potassium compound (Junerqing)” NCT01761214 ↗ |